CONGIU, CENZO
 Distribuzione geografica
Continente #
EU - Europa 142.635
NA - Nord America 9.980
AS - Asia 3.772
SA - Sud America 559
Continente sconosciuto - Info sul continente non disponibili 331
AF - Africa 128
OC - Oceania 8
Totale 157.413
Nazione #
IT - Italia 133.393
US - Stati Uniti d'America 9.836
NL - Olanda 6.666
CN - Cina 1.441
SG - Singapore 1.408
UA - Ucraina 910
BR - Brasile 455
FI - Finlandia 402
SE - Svezia 354
DE - Germania 333
VN - Vietnam 287
GB - Regno Unito 222
FR - Francia 208
HK - Hong Kong 130
IN - India 112
KR - Corea 101
CA - Canada 85
BD - Bangladesh 55
MA - Marocco 47
RU - Federazione Russa 41
AR - Argentina 38
MX - Messico 29
JP - Giappone 28
EG - Egitto 26
IQ - Iraq 25
PK - Pakistan 24
ES - Italia 21
EC - Ecuador 20
TR - Turchia 20
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 17
VE - Venezuela 16
AT - Austria 13
CO - Colombia 12
IR - Iran 12
SA - Arabia Saudita 12
JO - Giordania 11
TN - Tunisia 11
UZ - Uzbekistan 10
MY - Malesia 9
PT - Portogallo 9
TW - Taiwan 9
AZ - Azerbaigian 8
JM - Giamaica 8
PH - Filippine 8
TH - Thailandia 8
CL - Cile 7
CR - Costa Rica 7
IE - Irlanda 7
IL - Israele 7
OM - Oman 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
EU - Europa 6
HU - Ungheria 6
KE - Kenya 6
PE - Perù 6
NP - Nepal 5
DZ - Algeria 4
LT - Lituania 4
NG - Nigeria 4
RS - Serbia 4
DK - Danimarca 3
HN - Honduras 3
KZ - Kazakistan 3
RO - Romania 3
UY - Uruguay 3
CI - Costa d'Avorio 2
GA - Gabon 2
LB - Libano 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
PY - Paraguay 1
RE - Reunion 1
Totale 157.086
Città #
Cagliari 130.381
Amsterdam 6.650
Uta 2.489
Ashburn 949
Woodbridge 893
Fairfield 742
Singapore 612
San Jose 547
Chandler 539
Houston 539
Jacksonville 522
Wilmington 432
Ann Arbor 416
Dallas 413
Boardman 394
Seattle 306
Cambridge 282
Helsinki 252
Nyköping 247
Beijing 223
Council Bluffs 175
Dearborn 154
Nanjing 148
Los Angeles 131
Boston 125
Santa Clara 124
Hefei 120
Lauterbourg 115
Hong Kong 103
Ho Chi Minh City 94
The Dalles 91
Munich 90
Seoul 84
New York 79
Shanghai 74
Buffalo 71
Milan 64
Nanchang 62
Hanoi 55
Shenyang 53
Hebei 46
San Diego 45
São Paulo 44
Toronto 43
Guangzhou 40
Verona 40
Jiaxing 39
Tianjin 37
Changsha 34
Redwood City 34
Dong Ket 32
Casablanca 31
Mountain View 29
Redondo Beach 29
Atlanta 28
Chicago 28
Auburn Hills 23
Norwalk 23
Olbia 23
Washington 23
Orange 21
Brooklyn 20
Phoenix 20
Frankfurt am Main 19
Tokyo 19
Zhengzhou 19
Jinan 17
London 17
Rome 16
Turku 16
Chennai 15
Columbus 15
Selargius 15
Belo Horizonte 14
Ferrara 14
Hangzhou 14
San Francisco 14
Sassari 14
Falls Church 13
Naples 13
Brussels 12
Cairo 12
Da Nang 12
Dhaka 11
Manchester 11
Ningbo 11
Nuremberg 11
Orem 11
Perugia 11
Philadelphia 11
Quito 11
Wuhan 11
Amman 10
Denver 10
Haiphong 10
Rio de Janeiro 10
Kunming 9
Montreal 9
Springfield 9
Baghdad 8
Totale 151.046
Nome #
Synthesis and antiproliferative activity of 2,6-Dibenzylamino-3,5-dicyanopyridines on human cancer cell lines 12.509
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents 6.619
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen 4.913
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.614
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.879
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.747
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.725
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.679
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.610
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.549
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.539
Critical role for prokineticin 2 in CNS autoimmunity 2.479
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.374
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide 2.364
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.360
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.258
Synthesis and evaluation of new pyrazole-based carboxamides as modulators of the TrPv1 channel 2.225
New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity 2.214
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 2.138
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.130
Simple synthesis of polyfunctional nitropyridines 2.094
A new and efficient synthesis of phthalazin-1(2H)-ones 2.076
Synthesis of triflouromethylated pyridinecarbonitriles 2.061
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.059
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 2.018
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.983
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.917
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.853
An important role for prokineticin 2 in autoimmune CNS demyelination 1.827
PPAR controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development 1.816
Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives 1.810
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.797
null 1.768
Reaction of enaminonitriles with isocyanates. Synthesis of new 2-oxo- and 6-oxopyrimidines 1.764
null 1.650
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.493
DESIGN, SYNTHESIS, AND EVALUATION OF (ISO)NIPECOTAMIDE AND PIPERAZINYLUREA DERIVATIVES AS TRPV1 MODULATORS 1.409
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.356
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.304
New trifluoromethylated pyridines from functionalized N-1-acylacetamidrazones 1.262
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.254
null 1.242
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.176
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties 1.101
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 915
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 856
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 837
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 830
Reactivity of N1-Acylacetamidrazones towards Diethyl Acetylenedicarboxylate: Cyclization to Ethyl Pyrroleacetates and 1-Acylaminopyridones 829
null 825
Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives 757
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives 739
null 731
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors 729
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines 720
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 719
null 670
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents 666
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF DUAL FAAH – COX INHIBITORS 634
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues 624
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6- trifluoromethyl-3-pyridinecarboxylic acids 623
null 613
Synthesis and structural studies of 3-acylamino-4-amino-2,3-dihydro-2-iminothiazole-5-carboxylates and 4-acylhydrazino-2-aminothiazole-5-carboxylates 579
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 572
Synthesis and antimicrobial activity of some pyrrole derivatives 530
Synthesis and antimicrobial activity of some 1-arylideneamino-2-mercaptoimidazole derivatives 501
null 466
Synthesis and antimicrobial activity of some pyrrole derivatives. III. 2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives. 458
null 457
Synthesis and antimicrobial activity of some pyrrole derivatives. IV. 2-arylidenhydrazino-3-ethoxycarbonyl (or cyano) pyrrole derivatives. 450
Design, synthesis and pharmacological investigation on new FAAH inhibitors 448
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides 441
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF NEW FAAH INHIBITORS 438
Attività antimicrobica di derivati pirrolici 428
PROGETTAZIONE, SINTESI, STUDI SAR E VALUTAZIONE BIOLOGICA DI NUOVIINIBITORI DELL’ENZIMA FAAH 427
null 424
null 416
null 414
Synthesis and structure of heterocyclic compounds, 1-amino-2,4-disubstituted imidazoles. 397
Synergistic activity between rifamycins and a new class of isothiosemicarbazones against Mycobacterium avium 393
Synthesis of 1-acyl-5-pyrazolones and pyrrolidino [2,3-c]pyrazol-3-ones 393
Design, Synthesis, Biological Activity and SAR of New FAAH Inhibitors 391
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifampicina e rifabutina nei confronti di Mycobacterium avium 389
Synthesis and antifungal activities of N-arylideneaminoimidazole derivatives. 387
Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives. 385
Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives 380
null 378
DERIVATI DIARILETEROCICLICI COME POTENZIALI AGENTI ANTITUMORALI 374
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis 363
Synthesis and antimycobacterial activity of new S-alkylisotiosemicarbazone derivatives 362
null 361
Attività Antimicobatterica di Nuovi S-alchilisotiosemicarbazoni e Potenziamento dell’Attività di Rifampicina e Rifabutina nei Confronti di M. Avium 358
null 350
Synthesis and Antitubercular activity of N1-Isonicotinoylamidrazones Derivatives 348
Concentrazioni sub-inibenti di isonicotinoilidrazoni potenziano l'attività di rifampicina e etambutolo nei confronti di Mycobacterium tuberculosis 345
Synergistic Activity between Rifamycins and a New Class of Isothiosemicarbazones against Mycobacterium avium 344
null 341
null 341
Synthesis of pyridines by heterocyclization of new dienamino esters. 334
null 332
Totale 136.827
Categoria #
all - tutte 208.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.109 0 0 0 236 225 315 313 293 281 470 353 623
2022/20237.334 730 726 657 519 535 908 490 1.070 467 345 575 312
2023/20249.379 422 365 449 713 975 1.628 1.563 546 446 645 743 884
2024/202555.285 20.762 13.225 13.053 2.052 1.635 1.129 1.205 155 327 1.260 194 288
2025/202611.723 299 410 844 747 289 352 950 577 5.939 820 393 103
2026/20271.240 172 256 667 145 0 0 0 0 0 0 0 0
Totale 157.413